Description of the participants
Eligibility was assessed for 125 participants, of which 11 did not meet the inclusion criteria, and 10 met the exclusion criteria (Participant flow diagram of the study.Baseline demographic and clinical characteristicsData are presented as the number (proportion) of patients unless otherwise indicated. UP-TAU, Unified Protocol with Treatment As Usual; WL-TAU, Wait-list with Treatment As Usual; SSRI, Selective Serotonin Reuptake Inhibitors; SNRI, Serotonin Norepinephrine Reuptake Inhibitors; NaSSA, Noradrenergic and Specific Serotonergic Antidepressant.